CJC-1295 is a synthetic analogue of growth hormone releasing hormone (GHRH) that increases plasma levels of growth hormone and insulin-like growth factor 1 (IGF-1). DAC is an additive moiety that prolongs the plasma half-life of CJC-1295.
Bond Peptides CJC-1295 5MG Vial
$69.99
CJC-1295, a synthetic innovation of growth hormone-releasing hormone (GHRH), with or without DAC, elevates growth hormone and IGF-1 levels, offering a new horizon in muscle growth, wound healing, fat loss, and metabolic health research. Its extended half-life due to DAC inclusion enhances its efficacy in promoting sustained growth hormone release. This peptide is a cornerstone in studies aimed at harnessing the body’s natural growth mechanisms to improve muscle repair, bone density, and overall metabolic health, making it a critical asset in growth hormone research in animals.